Patent · US Active

PRMT5 inhibitors

US11098059B2 · kind B2 · utility

0Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 5, 2018
Grant dateAug 24, 2021
Priority date—
Expiry dateNov 5, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D453/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a compound of Formula (I) or the pharmaceutically acceptable salts thereof, which are PRMT5 inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.